Coverage
-
November 02, 2018
A Maylasian pharmacy company has urged a California federal court not to pause an order confirming a $3.49 million arbitral award it won against EHealthline.com over a failed project to build a pharmaceutical manufacturing facility in Saudi Arabia, calling the software company's bid "the latest episode in a now-familiar pattern of behavior."
2 other articles on this case.
View all »